| AAO | Age of Onset AD Alzheimer’s Disease |
| AIMS | Abnormal involuntary movement |
| ALS | Amyotrophic Lateral Sclerosis |
| AOIM | Age of Onset of Involuntary Movements |
| AOPC | Age of Onset of Psychological Changes |
| BMI | Body Mass Index |
| BBB | Blood Brain Barrier |
| CAG | Cytosine Adenosine Guanine |
| CNS | Central Nervous System |
| DA | Dopamine |
| EHDN | European Huntington’s Disease Network |
| FFQ | Food Frequency Questionnaire |
| GABA | Gamma-Aminobutyric acid |
| HD | Huntington’s Disease |
| HPD | High Protein Diet |
| HTT | Huntingtin |
| IS | Independence Score |
| ITT | Intent to treat |
| LACC | L-acetyl carnitine |
| MD | Mediterranean Diet |
| mHTT | Mutant Huntingtin |
| MMSE | Mini Mental State Examination |
| MUFA | Monounsaturated Fatty Acids |
| NR | Not Reported |
| 3-NP | 3-Nitropmiddleionic acid |
| NS | Non-significant |
| PD | Parkinson’s Disease |
| PP | Protocol Violation |
| PUFA | Polyunsaturated Fatty Acids |
| RCT | Randomized Controlled Trial |
| RP | Rate of progression |
| SFA | Saturated Fatty Acids |
| TFC | Total Functional Capacity |
| TMS | Total Motor Score |
| UA | Uric Acid |
| UHDRS | Unified Huntington’s Disease Rating Scale |